Gene: ANP32E
Official Full Name: acidic nuclear phosphoprotein 32 family member Eprovided by HGNC
Gene Summary: Enables histone binding activity; histone chaperone activity; and protein folding chaperone. Predicted to be involved in regulation of apoptotic process. Located in nucleus. Part of Swr1 complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25698 | ANP32E Knockout cell line (HeLa) | Human | ANP32E | 1:3~1:6 | Negative | Online Inquiry |
KO25699 | ANP32E Knockout cell line (HCT 116) | Human | ANP32E | 1:2~1:4 | Negative | Online Inquiry |
KO25700 | ANP32E Knockout cell line (HEK293) | Human | ANP32E | 1:3~1:6 | Negative | Online Inquiry |
KO25701 | ANP32E Knockout cell line (A549) | Human | ANP32E | 1:3~1:4 | Negative | Online Inquiry |
ANP32E Gene Knockout Cell Lines represent a cutting-edge tool designed for exploring the role of the ANP32E gene in various biological processes. These genetically modified cell lines are created using advanced CRISPR-Cas9 technology, which allows for precise deletion of the ANP32E gene. As a result, researchers can study the functional consequences of gene depletion on cellular behavior, phenotype, and signaling pathways, helping to elucidate ANP32E's contributions to cellular processes, including apoptosis, differentiation, and immune responses.
The primary mechanism underlying the utility of ANP32E Gene Knockout Cell Lines lies in their ability to create a controlled environment in which the effects of gene knockout can be systematically analyzed. Researchers can leverage these cell lines to investigate the gene’s role in disease models, drug response studies, or developmental biology. Furthermore, utilizing gene knockout models allows for the identification of compensatory mechanisms and pathway interdependencies, thus providing valuable insights into complex biological systems.
In the scientific community, ANP32E's involvement in various diseases—including certain cancers and metabolic disorders—underscores the significance of this product for both research and potential therapeutic applications. By employing ANP32E knockout lines, researchers and clinicians alike can expedite their investigations and develop targeted therapies, making it an invaluable asset in the laboratory.
Compared to alternative models or other gene editing approaches, ANP32E Gene Knockout Cell Lines offer enhanced specificity and efficiency, minimizing off-target effects. Their robust performance in a variety of assays makes them a preferred option for in-depth functional studies and experimental reproducibility.
For researchers and clinicians aiming to unravel the complexities of gene function or seeking to develop novel therapeutic strategies, ANP32E Gene Knockout Cell Lines provide a powerful resource. As a company dedicated to advancing biological research, we are committed to delivering high-quality products that empower the scientific community. With our extensive expertise in cell line development and gene editing technologies, we ensure that our offerings meet the rigorous needs of researchers and contribute to groundbreaking discoveries in biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.